Matthew Robert Berry

Matthew Robert Berry serves as an Assistant Professor in Veterinary Clinical Medicine at the University of Illinois, where he conducts research at the intersection of veterinary oncology and pharmacology. His work focuses on developing cancer treatments that benefit both canine patients and human medicine through comparative approaches, with particular expertise in brain cancer therapeutics and drug resistance mechanisms.

Dr. Berry's research program centers on veterinary oncology with a strong emphasis on canine cancer models as translational platforms. His work investigates biomarkers like PSMA expression in canine uroepithelial carcinomas, develops strategies to overcome drug efflux mechanisms involving P-glycoprotein, and explores novel compounds that evade resistance to temozolomide. His research portfolio demonstrates how veterinary clinical cases can inform human oncology while simultaneously advancing cancer care for companion animals.

Analysis of Dr. Berry's recent publications reveals a cohesive research trajectory focused on overcoming treatment barriers in oncology. His work spans multiple subfields including brain cancer therapeutics, drug resistance mechanisms, biomarker discovery, and novel compound development. A recurring theme is developing strategies to bypass biological barriers like the blood-brain barrier and drug efflux pumps. His research has significant translational potential, with findings from canine cancer patients informing human therapeutic development.

Dr. Berry has received the following recognition:

• AKC Canine Health Foundation Clinical-Scientist Fellowship (2024)

Dr. Berry maintains active collaborations across disciplines including chemistry, pharmacology, and human oncology. His work on novel compounds that evade resistance mechanisms shows promise for both veterinary and human applications. While specific grant details aren't provided in the available text, his AKC Canine Health Foundation fellowship supports his clinical-scientist work that bridges veterinary practice and translational research. His research demonstrates how veterinary clinical cases can serve as valuable models for human therapeutic development.

Though specific laboratory details aren't explicitly stated in the provided text, Dr. Berry's research appears to involve extensive cell culture models, canine patient studies, and close collaboration with chemistry researchers for drug development. His work connects veterinary clinical practice with basic science research through the comparative oncology approach, creating a bidirectional flow of knowledge between human and veterinary medicine.